Tag: RSV

March 3, 2022 Off

Pfizer’s RSV Vaccine Candidate Receives Breakthrough Therapy Designation for US

Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the…

March 27, 2019 Off

Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/RSV?src=hash” target=”_blank”gt;#RSVlt;/agt;–Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced…